Patients face safety risks with counterfeit and compounded prescription weight-loss drugs

Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges. Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity. The injectables – GLP-1s like semaglutide and incretins that are commonly known as…

[...]

FDA Warns Consumers to Beware Bogus Diabetes Treatments

Images of bogus diabetes treatments courtesy of the FDA. The U.S. Food and Drug Administration (FDA) is warning diabetics to beware of illegal “natural” remedies for the treatment of diabetes. They pose a serious health danger to diabetics, and are part of the growing trend amongst drug counterfeiters pushing fake natural medications. The FDA has…

[...]

FDA Warns Public About Stolen Levemir Insulin

Novo Nordisk product previously reported as stolen in North Carolina has resurfaced recently at a medical center in Houston. Originally posted June 16, 2009 FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not have been…

[...]

Counterfeit Insulin Needles Found in the UK

Counterfeit Insulin Needles Found in UK View Larger Map What: A batch of counterfeit insulin pen needles emulating those made by Novo Nordisk were discovered in the United Kingdom. According to the Juvenile Diabetes Research Foundation in England, “the needles were not made by Novo Nordisk, the manufacturer of NovoFine® and do not comply with…

[...]